Korean new drug ‘Noltec’ draws series of interests from foreign markets

Published: 2016-09-06 14:55:36

Updated: 2016-09-06 14:55:36

The value of the 14^th Korean drug, ‘Noltec(Ilyang Pharmcaeutical),’ is being stressed again as getting interests from foreign markets. It has shown a favorable trend as entering in the top 5 of the Korean PPI agent market this year.

The Ministry of Health and Welfare announced on the 4^th Ilyang Pharmaceutical accomplished a USD 200 million(approximately KRW 223.4 billion) license agreement of ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.